Author Guidelines

Contents

1. Submission
2. Aims and Scope
3. Manuscript Categories and Requirements
4. Preparing Your Submission
5. Editorial Policies and Ethical Considerations
6. Author Licensing
7. Publication Process After Acceptance
8. Post Publication
 9. Editorial Office Contact Details

1. SUBMISSION

Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

New submissions should be made via the Research Exchange submission portal https://submission.wiley.com/journal/ejh  Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at anytime by logging on to submission.wiley.com and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected].

Data protection
By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.

Preprint policy
This journal will consider for review articles previously available as preprints on non-commercial servers such as ArXiv, bioRxiv, psyArXiv, SocArXiv, engrXiv, etc. Authors may also post the submitted version of a manuscript to non-commercial servers at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
For help with submissions, please contact: [email protected]

2. AIMS AND SCOPE

European Journal of Haematology is an international journal for communication of basic and clinical research in haematology. The journal welcomes manuscripts on molecular, cellular and clinical research on diseases of the blood, vascular and lymphatic tissue, and on basic molecular and cellular research related to normal development and function of the blood, vascular and lymphatic tissue. The journal also welcomes reviews on clinical haematology and basic research, case reports, and clinical pictures.

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

When submitting your paper, please provide a novelty statement concerning your presented findings using the questions below. Please include this on the title page of your manuscript. Upon acceptance, they will be presented within the article. 

  1. What is the new aspect of your work?
  2. What is the central finding of your work? 
  3. What is (or could be) the specific clinical relevance of your work?

MANUSCRIPT TYPES
European Journal of Haematology accepts the following manuscript types:

Original Articles
Manuscripts containing original research from all fields in haematology are considered for publication. It is understood that neither the article nor any of its essential parts has been or will be published elsewhere, with the exemption of presentations at scientific meetings. For organization of the manuscript see below. Manuscripts must not exceed 4,000 words excluding abstract, references, tables, figures and legends. A maximum of 50 references is allowed. A maximum of six figures or tables is allowed. Additional figures/tables must be clearly marked as supplemental and will be published as such only electronically.

Please include the following information in the title page of your manuscript:

Novelty Statement

  1. What is the NEW aspect of your work? (ONE sentence)
  2. What is the CENTRAL finding of your work? (ONE sentence)
  3. What is (or could be) the SPECIFIC clinical relevance of your work? (ONE sentence)


Review Articles
Review articles on recent developments or history of haematology may be solicited by the Editor-in-Chief. Suggestions are welcomed in the form of a one-page synopsis. Review articles must be exhaustive and should include appropriate reference to the literature. Review articles will go through the usual peer-review process before a final decision regarding publication is made. Manuscripts must not exceed 6,000 words excluding abstract, references, tables, figures and legends. A maximum of 80 references is allowed.

Letters to the Editor
European Journal of Haematology welcomes critical or ancillary comments to manuscripts published in the journal. These should be addressed to the Editor-in-Chief, indicating that they are regarded as a “letter to the editor” and not as an original article. They may contain one table or figure and should not be more than 500 words. The editor reserves the right to edit the letters for clarity. A title must accompany the letter. If you wish to submit a response to a published letter please select the category ‘Response’.

Case Reports
European Journal of Haematology accepts a very limited number of case reports. These must provide fundamental new information on a relevant topic. Sole descriptions of unusual or rare clinical cases without a clear impact for future research are not sufficient to be published in this category. Reports must be instructive and contain a critical review of the literature related to the presented case. Case reports must not exceed 1,000 words excluding references, tables, figures and legends. A maximum of 2 tables or figures and 5 references is allowed.

Clinical Pictures
As of 01.03.2015 this manuscript category will be closed and no submissions accepted.

Plain Language Summaries 
The Plain Language Summary should convey the same information as the Abstract for a lay audience. It should summarize your scientific study, its results, and their broader relevance without using jargon so that it is understandable by patients, scientists from outside of your discipline, as well as science journalists and science educators. The Plain Language Summary should be a single paragraph no more than 200 words long. Plain Language Summaries should be submitted as a separate submission and must clearly reference which article it relates to by using the title format ‘Plain Language Summary on Article Title’. If you wish to submit a Plain Language Summary after your paper has been accepted. 

4. PREPARING YOUR SUBMISSION

Cover Letters
A covering letter must be included, signed by the corresponding author and stating on behalf of all the authors that the work has not been published and is not being considered for publication elsewhere.

Submission format

Submissions via the new Research Exchange portal can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. Should your manuscript reach revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx) or LaTex (.tex) formats.

If submitting your manuscript file in LaTex format via Research Exchange, select the file designation “Main Document – LaTeX .tex File” on upload. When submitting a Latex Main Document, you must also provide a PDF version of the manuscript for Peer Review. Please upload this file as “Main Document - LaTeX PDF.” All supporting files that are referred to in the Latex Main Document should be uploaded as a “LaTeX Supplementary File.”

Cover Letters and Conflict of Interest statements may be provided as separate files, included in the manuscript, or provided as free text in the submission system. A statement of funding (including grant numbers, if applicable) should be included in the “Acknowledgements” section of your manuscript.

Title page
The title page should contain an informative title, author(s)'s names and their affiliations. Name, address, telephone and fax numbers and e-mail address of the corresponding author. If the title exceeds 40 characters (letters and spaces) a running title of no more than 40 characters must be supplied. The following information is also required on the title:

  • Abstract word count
  • Manuscript word count
  • Number of references
  • Number of figures and tables
  • Number of supplemental illustrations/tables

Authorship
On initial submission, the submitting author will be prompted to provide the email address and country for all contributing authors.

Acknowledgments
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the ‘Conflict of Interest’ section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

Abstract and Keywords
The abstract must not exceed 200 words and should be arranged in a structured fashion (to include objectives, methods, results and conclusions.) It should state the purpose of the study, basic procedures (study subject /patients/animals and methods), main findings (specific data and statistical significance), and principal conclusions. Below the abstract, provide 3-10 key words that will assist indexers in cross-indexing the article. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at https://www.nlm.nih.gov/mesh/.

Main body of text

  • As papers are single-blind peer reviewed, the main text file should not include any information that might identify the authors.
  • The journal uses British/US spelling; however, authors may submit using either option, as spelling of accepted papers is converted during the production process.
  • Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

Methods and Materials
If a method or tool is introduced in the study, including software, questionnaires, and scales, the author should state the license this is available under and any requirement for permission for use. If an existing method or tool is used in the research, the authors are responsible for checking the license and obtaining the permission. If permission was required, a statement confirming permission should be included in the Methods and Materials section.

References
Number references consecutively in the order in which they are first mentioned in the text. Identify references in text, tables and legends by Arabic numerals (in parentheses). All references cited, and only these, must be listed at the end of the paper. References should be according to the style used in Index Medicus and the International List of Periodical Title Word Abbreviations (ISO 833). All authors must be listed.

Examples:

Standard journal articles
1. International Steering Committee. Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 1997; 336: 309.
2. Cieutat AM, Lobel P, August JT, Kjeldsen L, Sengelov H, Borregaard N, Bainton DF. Azurophilic granules of human neutrophilic leukocytes are deficient in lysosome-associated membrane proteins but retain the mannose 6-phosphate recognition marker. Blood 1998; 91: 1044-1058.

Chapter in a book
3. Philips DJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis, and management, 2nd ed. New York: Raven Press, 1995: 465-478.

Proceedings
4. Rausch C, Murgatroyd PW, Schnickelheim Z, eds. Cerebral glucose utilization testing. New York: Medical Press, 1989:141-149.

Endnotes
Endnotes should be placed as a list at the end of the paper only, not at the foot of each page. They should be numbered in the list and referred to in the text with consecutive, superscript Arabic numerals. Keep endnotes brief; they should contain only short comments tangential to the main argument of the paper.

Footnotes
Footnotes should be placed as a list at the end of the paper only, not at the foot of each page. They should be numbered in the list and referred to in the text with consecutive, superscript Arabic numerals. Keep footnotes brief; they should contain only short comments tangential to the main argument of the paper and should not include references.

Tables
Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure Legends
Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Figures
Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.
Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.

Color figures.
Figures submitted in color will be reproduced in color free of charge. Authors are encouraged to consider the accessibility of their figures to readers with color-blindness or other visual impairments. If greyscale or monochrome figures are not possible, authors should consider limiting the use of color and avoid palettes that cause difficulty for readers with colour-blindness, such as green/red.
It is preferable that line figures (e.g. graphs and charts) are supplied in black and white’ however, where greyscale or monochrome figures are not possible, authors should consider limiting the use of colour and avoid palettes that cause difficulty for readers with color-blindness, such as green/red.

Data Citation
In recognition of the significance of data as an output of research effort, Wiley has endorsed In recognition of the significance of data as an output of research effort, Wiley has endorsed the FORCE11 Data Citation Principles and is implementing a mandatory data citation policy. Wiley journals require data to be cited in the same way as article, book, and web citations and authors are required to include data citations as part of their reference list.

Data citation is appropriate for data held within institutional, subject focused, or more general data repositories. It is not intended to take the place of community standards such as in-line citation of GenBank accession codes.

When citing or making claims based on data, authors must refer to the data at the relevant place in the manuscript text and in addition provide a formal citation in the reference list. We recommend the format proposed by the Joint Declaration of Data Citation Principles:

  • [dataset] Authors; Year; Dataset title; Data repository or archive; Version (if any); Persistent identifier (e.g. DOI)

Additional Files

Appendices
Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text.

Supporting Information
Supporting information is information that is not essential to the article but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.

Click here for Wiley’s FAQs on supporting information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

General Style Points
The following points provide general advice on formatting and style.

  • Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly, and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
  • Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website for more information about SI units.
  • Numbers: numbers under 10 are spelt out, except for: measurements with a unit (8mmol/l); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).
  • Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.

Wiley Author Resources

Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, we encourage authors to consult Wiley’s best practice tips on Writing for Search Engine Optimization.

Article Preparation Support
Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.    

 

5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS

Peer Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determine that the paper meets the appropriate quality and relevance requirements.

Wiley's policy on confidentiality of the review process is available here.

Refer and Transfer Program
Wiley believes that no valuable research should go unshared. This journal participates in Wiley’s Refer & Transfer program. If your manuscript is not accepted, you may receive a recommendation to transfer your manuscript to another suitable Wiley journal, either through a referral from the journal’s editor or through our Transfer Desk Assistant.

Guidelines on Publishing and Research Ethics in Journal Articles Please review Wiley’s policies surrounding human studies, animal studies, clinical trial registration, biosecurity, and research reporting guidelines here.

Species Names
Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.

Genetic Nomenclature
Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see http://varnomen.hgvs.org/, where examples of acceptable nomenclature are provided.

Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:

Proteins sequence data should be submitted to either of the following repositories:

Conflict of Interest
The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to, patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

Funding
Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: http://www.crossref.org/fundingdata/registry.html

Authorship
The journal follows the ICMJE definition of authorship, which indicates that authorship be based on the following 4 criteria:

  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  • Drafting the work or revising it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

In addition to being accountable for the parts of the work he or she has done, an author should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co-authors.

All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged. These authorship criteria are intended to reserve the status of authorship for those who deserve credit and can take responsibility for the work. The criteria are not intended for use as a means to disqualify colleagues from authorship who otherwise meet authorship criteria by denying them the opportunity to meet criterion #s 2 or 3. Therefore, all individuals who meet the first criterion should have the opportunity to participate in the review, drafting, and final approval of the manuscript.

Data Sharing and Data Accessibility
The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.

Data Citation
Please also cite the data you have shared, like you would cite other sources that your article refers to, in your references section. You should follow the format for your data citations laid out in the Joint Declaration of Data Citation Principles, https://www.force11.org/datacitationprinciples:

  • [dataset] Authors; Year; Dataset title; Data repository or archive; Version (if any); Persistent identifier (e.g. DOI)

Human subject information in databases. The journal refers to the World Health Medical Association Declaration of Taipei on Ethical Considerations Regarding Health Databases and Biobanks.

Publication Ethics
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here. The journal requires that you include in the manuscript details IRB approvals, ethical treatment of human and animal research participants, and gathering of informed consent, as appropriate. You will be expected to declare all conflicts of interest, or none, on submission. Please review Wiley’s policies surrounding human studies, animal studies, clinical trial registration, biosecurity, and research reporting guidelines: Best Practice Guidelines on Publishing Ethics | Wiley

ORCID
As part of our commitment to supporting authors at every step of the publishing process, Cytopathology requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information.

6. AUTHOR LICENSING

If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.

Authors may choose to publish under the terms of the journal’s standard copyright agreement, or open access under the terms of a Creative Commons License.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under OnlineOpen, please click here. (Note that certain funders mandate that a particular type of CC license has to be used; to check this please click here.)

Self-Archiving definitions and policies. Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.

Open Access fees: If you choose to publish using OnlineOpen you will be charged a fee. A list of Article Publication Charges for Wiley journals is available here.

Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.

7. PUBLICATION PROCESS AFTER ACCEPTANCE

Proofs
Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online guidelines are provided within the system. No special software is required, all common browsers are supported. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online system cannot be used or accessed.

Publication Charges

 

Early View The journal offers rapid publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as Editors also need to review proofs. Before we can publish an article, we require a signed license (authors should login or register with Wiley Author Services. Once the article is published on Early View, no further changes to the article are possible. The Early View article is fully citable and carries an online publication date and DOI for citations.

Citing this Article: eLocators
This journal now uses eLocators. eLocators are unique identifies for an article that service the same function page numbers have traditionally served in the print world. When citing this article, please insert the eLocator in place of the page number. For more information, please visit the Author Services eLocator page here.

8. POST PUBLICATION

Access and sharing
When your article is published online:

  • The author receives an email alert (if requested).
  • The link to the published article can be shared through social media.
  • The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
  • For non-open access articles, the corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.

Promoting the Article
Find out how to do that here.

Article Promotion Support
Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.

Measuring the Impact of your Work
Wiley also helps you measure the impact of your research through our specialist partnerships with Kudos and Altmetric.

Archiving Services
Portico and CLOCKSS are digital archiving/preservation services we use to ensure that Wiley content will be accessible to customers in the event of a catastrophic event such as Wiley going out of business or the platform not being accessible for a significant period of time. Member libraries participating in these services will be able to access content after such an event. Wiley has licenses with both Portico and CLOCKSS, and all journal content gets delivered to both services as it is published on Wiley Online Library. Depending on their integration mechanisms, and volume loads, there is always a delay between content being delivered and showing as “preserved” in these products.

9. EDITORIAL OFFICE CONTACT DETAILS

For queries about submissions, please contact: [email protected]